PHARMACYTE BIOTECH, INC. Investment Owned, Percent of Net Assets
PHARMACYTE BIOTECH, INC. (PMCB) had Investment Owned, Percent of Net Assets of 14.50% as of 2016-04-30, per its 10-K filed 2016-07-29.
Discontinued › Notes
us-gaap:InvestmentOwnedPercentOfNetAssets · last filed 2016-07-29
- 2016-04-30: Investment Owned, Percent of Net Assets 14.50%.
| Period end | Investment Owned, Percent of Net Assets |
|---|---|
| 2016-04-30 | 14.50% 10-K · filed 2016-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |